MyDay® MiSight® 1 day
Clinically proven to cut the worsening of short-sightedness by approximately half.*1
 
Act early to help slow the worsening of your child’s short-sightedness with MyDay® MiSight® 1 day contact lenses†1,2

As myopia (short-sightedness) gets worse, it can impact quality of life. This is because children become increasingly dependent on vision correction to fully participate in school, sports and other daily activities.3,4

MyDay® MiSight® 1 day contact lenses provide clear vision,‡2,5,6 using technology developed for MiSight® 1 day,§5 the first soft contact lens proven to slow the worsening of myopia in children.◊5

By helping to slow the worsening of myopia, myopia management contact lenses can support your child’s visual wellbeing today and help protect the quality of their vision as they grow.3,4

When your child wears MyDay® MiSight® 1 day contact lenses, they can experience clear vision and freedom from glasses5 while enjoying the activities they love. Children as young as 8 can confidently apply contact lenses,7 and 100% of children reported being happy with the overall comfort of MyDay® MiSight® 1 day contact lenses.¶6

To start your child’s journey to a clearer future, ask your optician about MyDay® MiSight® 1 day.

 
Explore Harry’s story
Discover Immy's journey with myopia and how MiSight® 1 day contact lenses are helping her to achieve her dreams of being a gymnast.
Explore Harry’s story
Follow Harry’s journey - from blurry boards to clear goals.
Explore Immy’s story
Discover Immy's journey with myopia and how MiSight® 1 day contact lenses are helping her to achieve her dreams of being a gymnast.
Explore Millie’s story
Learn how MiSight® 1 day gave Millie the freedom she’d been waiting for.
Hear from the experts
Find out why specialist optometrist, Indie Grewal, recommends myopia management for his young short-sighted patients.
I have been an eye care professional for 30 years, and I am delighted that we now have a clinically proven product that can cut the worsening of short-sightedness in children.*1
Indie Grewal, Specialist Optometrist
MiSight® 1 day contact lenses are child-friendly2
In our clinical study with MiSight® 1 day contact lenses in children, we found that they:


Cuts worsening of myopia by approximately 50%*1,2


Works for nearly all children with myopia, with 90% of eyes responding to treatment††2,9


Works at any age the child starts treatment**1,2


The 7-year clinical trial of ActivControl® Technology is the longest-running soft contact lens study among children




Application and removal guide



Myopia symptoms in children
Myopia can worsen rapidly, particularly in younger children, so it's important to start treatment as soon as possible.10
Learn more about myopia symptoms in children.


Vision simulator
Myopia is more than just blurry vision — It can lead to an increased risk of serious vision problems later in life.11-14
Find out what myopia looks like through your child’s eyes.


Myopia quiz
Take our quiz to find out if your child could become myopic and what to do if they already are.

* Using measured and modelled data, pooled across ages (8-17), myopia progression was slowed by an average of approximately 50% with MiSight® 1 day, which shares the same ActivControl® Technology with MyDay® MiSight® 1 day.
Children with myopia ages 8-15 experienced slowed myopia progression when starting treatment with MiSight® 1 day, which shares the same ActivControl® Technology with MyDay® MiSight® 1 day.
MyDay® MiSight® 1 day contact lenses use the same ActivControl® Technology as the original MiSight® 1 day.
§ Proven to slow myopia progression in children compared to a single vision 1-day lens over a 3-year period.
Compared to a single vision 1 day lens over a 3-year period.
Clinical study participants at the 1-week visit. 38% rated very happy, 53% rated happy, 9% rated slightly happy with overall comfort satisfaction.
†† 90% of myopic eyes respond to treatment with MiSight® 1 day (ages 11-15 at start of wear, n=90), which shares the same ActivControl® Technology with MyDay® MiSight® 1 day.
** As long as they remained wearing the lens as prescribed, children with myopia ages 8-15 continued to experience slowed myopia progression with MiSight® 1 day, which shares the same ActivControl® Technology with MyDay® MiSight® 1 day.

References
1. Arumugam B et al. Modelling Age Effects of Myopia Progression for the MiSight 1-day Clinical Trial. Invest. Ophthalmol. Vis. Sci. 2021; 62(8): 2333.
2. CVI data on file, 2025.
3. Lamoureux E L et al. Myopia and Quality of Life: The Singapore Malay Eye Study (SiMES). Invest. Ophthalmol. Vis. Sci. 2008; 49(13): 4469.
4. Chua SY et al (2020) The Economic and Societal Impact of Myopia and High Myopia: 53-63. In: Ang M. et al (eds) Updates on Myopia. Springer, Singapore.
5. Chamberlain P et al. A 3-year randomised clinical trial of MiSight® lenses for myopia control. Optom Vis Sci. 2019; 96(8): 556-567.
6. CVI data on file 2025. Prospective, 1-week, double masked, bilateral study with MyDay® MiSight® 1 day. N=32 subjects aged 8-18 years.
7. Lumb E et al. Six years of wearer experience in children participating in a myopia control study of MiSight® 1 day. Cont Lens Anterior Eye. 2023; 46(4): 101849.
8. CVI data on file 2025. Internal global wearer modelling estimates for the 12-month period of October 2024 to September 2025.
9. Chamberlain P et al. Long-term Effect of Dual-focus Contact Lenses on Myopia Progression in Children: A 6-year Multicentre Clinical Trial. Optom Vis Sci. 2022 Mar 1; 99(3): 204-212.
10. Zadnik K et al. Factors Associated with Rapid Myopia Progression in School Aged Children. Invest. Ophthalmic. Vis. Sci. 2004; 45(13): 2306.
11. Xu L et al. High myopia and glaucoma susceptibility, the Beijing Eye Study. Ophthalmology. 2007; 114(2): 216-20.
12. Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res. 2013; 31(6): 622-60.
13. Younan C et al. Myopia and incident cataract and cataract surgery: the blue mountains eye study. Invest. Ophthalmic. Vis. Sci. 2002; 43(12): 3625-3632.
14. Chen SJ et al. Prevalence and associated risk factors of myopic maculopathy in elderly Chinese: the Shihpai eye study. Invest. Ophthalmic. Vis. Sci. 2012; 53(8): 4868-73.

CVY06261873-1